-
in human fungal pathogens and to evaluate the efficacy and molecular targets of a novel antifungal therapeutic. The successful candidate will evolve drug-susceptible fungal isolates into antifungal
-
concentrations following deep energy-retrofits scenarios of the large-scale national renovation strategy. INFORM will utilise a building physics model (CONTAM), which will be parameterised based on representative
Searches related to molecular modeling
Enter an email to receive alerts for molecular-modeling positions